Jill Thompson

5PUBLICATIONS
35CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Innate immunityMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Sep 21, 2026
Immunodominant Antiviral T Cell Responses Outcompete Antitumor T Cell Responses to Reduce the Efficacy of Oncolytic Viroimmunotherapy.

|Aug 26, 2026
Cancer Immunotherapy Using AIRE Conditioning of the Tumor Epitopeome.

|Jun 05, 2026
Engagement of the TCR against an oncolytic virus generates a population of effector CAR T cells with potent antitumor activity.

|Oct 26, 2024
Intranasal Prime-Boost with Spike Vectors Generates Antibody and T-Cell Responses at the Site of SARS-CoV-2 Infection.

Muriel Metko, Jason Tonne, Alexa Veliz Rios

|Apr 13, 2022
Oncolytic virus-mediated expansion of dual-specific CAR T cells improves efficacy against solid tumors in mice.

Laura Evgin, Tim Kottke, Jason Tonne

Pageof 1

Frequent Collaborators

4 joint publications

Alan Melcher

3 joint publications

Richard Vile

3 joint publications

Benjamin L Kendall

3 joint publications

Thanich Sangsuwannukul